Gene · 699
Papers3,725
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
981 to 1,000 of 3,725
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CANVS: an easy-to-use application for the analysis and visualization of mass spectrometry-based protein-protein interaction/association data. | Mol Biol Cell | 2021 | 34432510 | PubTator, text mining | PubMed |
| Effects of Siberian fir terpenes extract Abisil on antioxidant activity, autophagy, transcriptome and proteome of human fibroblasts. | Aging (Albany NY) | 2021 | 34428743 | PubTator, text mining | PubMed |
| Dysregulation of microRNAs in metal-induced angiogenesis and carcinogenesis. | Semin Cancer Biol | 2021 | 34428550 | PubTator, text mining | PubMed |
| Identification of joint gene players implicated in the pathogenesis of HTLV-1 and BLV through a comprehensive system biology analysis. | Microb Pathog | 2021 | 34419613 | PubTator, text mining | PubMed |
| Weighted genes associated with the progression of retinoblastoma: Evidence from bioinformatic analysis. | Exp Eye Res | 2021 | 34419445 | PubTator, text mining | PubMed |
| NCAPG promotes the progression of lung adenocarcinoma via the TGF-β signaling pathway. | Cancer Cell Int | 2021 | 34419073 | PubTator, text mining | PubMed |
| Atezolizumab plus bevacizumab combination enables an unresectable hepatocellular carcinoma resectable and links immune exclusion and tumor dedifferentiation to acquired resistance. | Exp Hematol Oncol | 2021 | 34399826 | PubTator, text mining | PubMed |
| Promoting Prognostic Model Application: A Review Based on Gliomas. | J Oncol | 2021 | 34394352 | PubTator, text mining | PubMed |
| Identification of COVID-19 and Dengue Host Factor Interaction Networks Based on Integrative Bioinformatics Analyses. | Front Immunol | 2021 | 34394108 | PubTator, text mining | PubMed |
| Anti-malarial drug dihydroartemisinin downregulates the expression levels of CDK1 and CCNB1 in liver cancer. | Oncol Lett | 2021 | 34386075 | PubTator, text mining | PubMed |
| Second-Generation Antimitotics in Cancer Clinical Trials. | Pharmaceutics | 2021 | 34371703 | PubTator, text mining | PubMed |
| Multifunctionality of the Telomere-Capping Shelterin Complex Explained by Variations in Its Protein Composition. | Cells | 2021 | 34359923 | PubTator, text mining | PubMed |
| MicroRNA-490-3p and -490-5p in carcinogenesis: Separate or the same goal? | Oncol Lett | 2021 | 34345303 | PubTator, text mining | PubMed |
| Inhibition of BUB1 suppresses tumorigenesis of osteosarcoma via blocking of PI3K/Akt and ERK pathways. | J Cell Mol Med | 2021 | 34337852 | PubTator, text mining | PubMed |
| Types of potentials in a mitotic spindle. | Biochem Biophys Rep | 2021 | 34337166 | PubTator, text mining | PubMed |
| Prediction of Disease Genes Based on Stage-Specific Gene Regulatory Networks in Breast Cancer. | Front Genet | 2021 | 34335705 | PubTator, text mining | PubMed |
| Aurora kinase A (AURKA) promotes the progression and imatinib resistance of advanced gastrointestinal stromal tumors. | Cancer Cell Int | 2021 | 34332577 | PubTator, text mining | PubMed |
| Separase cleaves the kinetochore protein Meikin at the meiosis I/II transition. | Dev Cell | 2021 | 34331869 | PubTator, text mining | PubMed |
| A novel class of inhibitors that target SRSF10 and promote p53-mediated cytotoxicity on human colorectal cancer cells. | NAR Cancer | 2021 | 34316707 | PubTator, text mining | PubMed |
| High Expression Levels of CDK1 and CDC20 in Patients With Lung Squamous Cell Carcinoma are Associated With Worse Prognosis. | Front Mol Biosci | 2021 | 34307447 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/699/papers?page=50